Wilson Sonsini Goodrich & Rosati advised Cleanlab on the transaction. Cleanlab announced it closed $25 million in a Series A financing round co-led by Menlo Ventures and...
Cleanlab’s $25 Million Series A Financing Round
Soleno Therapeutics’ $120 Million Common Stock Offering and Private Placement
Wilson Sonsini Goodrich & Rosati and Cooley advised Soleno Therapeutics on the deal. Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno”) announced the pricing of the underwritten public offering of...
Endoxa’s Launch of Position Reporting Utility
Wilson Sonsini Goodrich & Rosati represented Droit in the transaction. Endoxa announced the collaboration of its five leading financial institutions including Barclays, BNP Paribas, Goldman Sachs, and...
Plenful’s $9 Million Seed Round
Wilson Sonsini Goodrich & Rosati advised Plenful on the transaction. Plenful announced $9 million in funding led by Bessemer Venture Partners and more than 20 enterprise customers...
Spark I Acquisition Corporation’s $100 Million Initial Public Offering
Wilson Sonsini Goodrich & Rosati advised Spark I Acquisition Corp. on the offering, and Ellenoff Grossman & Schole advised Cantor Fitzgerald & Co. Spark I Acquisition...
Nextdata’s $12 Million Seed Financing Round
Wilson Sonsini Goodrich & Rosati advised Nextdata on the transaction. Nextdata announced it has raised a total of $12 million in seed investment, led by Greycroft and Acrew Capital, with participation...
Iambic Therapeutics’ $100 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction. Iambic Therapeutics announced the closing of an oversubscribed $100 million Series B financing. The round was co-led by...
Synqly’s $4 Million Seed Financing Round
Wilson Sonsini Goodrich & Rosati advised Synqly on the transaction. Synqly, Inc. announced it emerged from stealth and raised $4 million in seed funding from SYN Ventures,...
JURA Bio’s $16.1 Million Financing and Replay Collaboration
Wilson Sonsini Goodrich & Rosati advised JURA Bio on both the financing transaction and the collaboration agreement. JURA Bio announced a research collaboration with Syena, a cell...
ZX Inc.’s HK$266 Million Hong Kong IPO
Kirkland & Ellis, Beijing Dacheng Law Offices, LLP, Goldsun Law Firm and Walkers (Hong Kong) represented ZX Inc., and Wilson Sonsini Goodrich & Rosati and JunHe...
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...
Adela’s $48 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised Adela on patent matters related to the transaction. Adela, Inc. announced the completion of a $48 million financing. The round included existing...